Medical University of Lodz, Łódź, Poland (Department of Pediatrics, Neonatal Pathology and Bone Metabolism Diseases).
Int J Occup Med Environ Health. 2022 Jun 8;35(3):273-283. doi: 10.13075/ijomeh.1896.01841. Epub 2021 Dec 9.
Assessment of the disease acceptance level in women with osteoporosis depending on selected sociodemographic factors.
The study included a group of 198 women, aged M±SD 72.3±8.59 years, diagnosed with postmenopausal osteoporosis and treated in 2 Osteoporosis Treatment Centres in Łódź. A questionnaire survey and A (AIS) were applied in the study. Based on the questionnaire, the authors collected sociodemographic data (including age, marital status, place of residence, financial status) which the authors subsequently analyzed using a statistical program.
The respondents living in the countryside, with primary education and a very difficult financial situation manifested a low disease acceptance level. The authors have shown that postmenopausal osteoporosis acceptance level significantly depends on the age (p = 0.0024), place of residence (p = 0.0044), education (p < 0.001) and affluence (p = 0.0049), however, it is not related to duration of the disease.
Postmenopausal osteoporosis acceptance level depended on age, place of residence, education and affluence level, however, it was not related to the disease duration. Psychological aspects, including assessment according to the disease acceptance scale, constitute a factor influencing mental health, therefore they should be included in evaluation of therapy effectiveness in patients chronically treated for osteoporosis. Int J Occup Med Environ Health. 2022;35(3):273-83.
评估骨质疏松症女性的疾病接受程度,依据选定的社会人口学因素。
研究纳入了 198 名年龄均数标准差为 72.3±8.59 岁的绝经后骨质疏松症女性患者,这些患者均在罗兹的 2 家骨质疏松治疗中心接受治疗。研究中应用了问卷调查和 A (AIS)。根据问卷,作者收集了社会人口学数据(包括年龄、婚姻状况、居住地、经济状况),并使用统计程序对其进行了分析。
居住在农村、接受过小学教育和经济状况非常困难的受访者表现出较低的疾病接受程度。作者表明,绝经后骨质疏松症的接受程度与年龄(p=0.0024)、居住地(p=0.0044)、教育程度(p<0.001)和富裕程度(p=0.0049)显著相关,而与疾病持续时间无关。
绝经后骨质疏松症的接受程度取决于年龄、居住地、教育程度和富裕程度,但与疾病持续时间无关。心理方面,包括根据疾病接受程度量表进行的评估,是影响心理健康的一个因素,因此应将其纳入对长期接受骨质疏松症治疗的患者的治疗效果评估中。国际职业医学与环境卫生杂志。2022;35(3):273-83.